Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana. (Q46847706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Leishmania donovani

1 reference

Leishmania mexicana

1 reference

11

Hira L Nakhasi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Ranadhir Dey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Gayathri Natarajan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Parna Bhattacharya

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Hannah Cummings

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Pradeep K Dagur

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

César Terrazas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Angamuthu Selvapandiyan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

John P McCoy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Robert Duncan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Abhay R Satoskar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

English

0 references

publication date

25 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

3513-3527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains

13 March 2020

cites work

1 reference

12 December 2020

Leishmania species: models of intracellular parasitism.

1 reference

12 December 2020

The host response to Leishmania infection.

1 reference

12 December 2020

Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome

1 reference

12 December 2020

The role of dendritic cells at the early stages of Leishmania infection

1 reference

12 December 2020

Dendritic cell regulation of TH1-TH2 development

1 reference

12 December 2020

Interleukin-10 and the interleukin-10 receptor

1 reference

12 December 2020

Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite.

1 reference

12 December 2020

Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization

1 reference

12 December 2020

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

1 reference

12 December 2020

The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.

1 reference

12 December 2020

An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.

1 reference

12 December 2020

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

12 December 2020

Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine

1 reference

12 December 2020

Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity

1 reference

12 December 2020

Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response

1 reference

12 December 2020

Generation of Leishmania donovani axenic amastigotes: their growth and biological characteristics

1 reference

12 December 2020

Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania

1 reference

12 December 2020

Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells

1 reference

12 December 2020

Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.

1 reference

12 December 2020

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

1 reference

12 December 2020

Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta)

1 reference

12 December 2020

Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.

1 reference

12 December 2020

Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts

1 reference

12 December 2020

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

1 reference

12 December 2020

Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

1 reference

12 December 2020

Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions

1 reference

12 December 2020

Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis

1 reference

12 December 2020

Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models

1 reference

12 December 2020

Chemotherapy in the treatment and control of leishmaniasis

1 reference

12 December 2020

Leishmania vaccines: progress and problems.

1 reference

12 December 2020

Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania

1 reference

12 December 2020

SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection

1 reference

12 December 2020

Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection

1 reference

12 December 2020

FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions

1 reference

12 December 2020

Live attenuated Leishmania vaccines: a potential strategic alternative

1 reference

12 December 2020

Mast cells are activated by Leishmania mexicana LPG and regulate the disease outcome depending on the genetic background of the host

1 reference

12 December 2020

Immunoregulatory roles of eosinophils: a new look at a familiar cell

1 reference

12 December 2020

A detrimental role for IgG and FcgammaR in Leishmania mexicana infection

1 reference

12 December 2020

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

1 reference

12 December 2020

Mast cell degranulation contributes to susceptibility to Leishmania major

1 reference

12 December 2020

Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection

1 reference

12 December 2020

Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions

1 reference

12 December 2020

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells

1 reference

12 December 2020

Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates

1 reference

12 December 2020

Vector transmission of leishmania abrogates vaccine-induced protective immunity

1 reference

12 December 2020

Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.

1 reference

12 December 2020

Histopathology of Leishmania major infection: revisiting L. major histopathology in the ear dermis infection model

1 reference

12 December 2020

Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection

1 reference

12 December 2020

Towards new tuberculosis vaccines

1 reference

12 December 2020

Immunopathological Studies ofLeishmania amazonensisInfection in Resistant and in Susceptible Mice

1 reference

12 December 2020

Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence

1 reference

12 December 2020

Rationalizing the development of live attenuated virus vaccines

1 reference

12 December 2020

IgG1 is pathogenic in Leishmania mexicana infection

1 reference

12 December 2020

Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation

1 reference

12 December 2020

Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites

1 reference

12 December 2020

Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection

1 reference

12 December 2020

Leishmaniasis worldwide and global estimates of its incidence

1 reference

12 December 2020

Leishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infection

1 reference

12 December 2020

Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice

1 reference

12 December 2020

Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans

1 reference

12 December 2020

Vaccination and treatment trials against murine leishmaniasis with semi-purified Leishmania antigens.

1 reference

12 December 2020

Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.

1 reference

12 December 2020

Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis

1 reference

12 December 2020

A radioattenuated Leishmania major vaccine markedly increases the resistance of CBA mice to subsequent infection with Leishmania mexicana mexicana

1 reference

12 December 2020

Development of a safe live Leishmania vaccine line by gene replacement.

1 reference

12 December 2020

Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

1 reference

12 December 2020

Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells

1 reference

12 December 2020

Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.

1 reference

12 December 2020

Vaccines against leishmaniasis.

1 reference

12 December 2020

Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease

1 reference

12 December 2020

Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection

1 reference

12 December 2020

Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.1303145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

PubMed publication ID

25156362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25156362%20AND%20SRC:MED&resulttype=core&format=json